Table 3.
Immune modulatory therapies associated with the development of progressive multifocal leukoencephalopathy
Drug name | Alternative names | Classification | Target |
---|---|---|---|
Tysabri | Natalizumab | Monoclonal antibody | α4-Chain of α4β1 integrin |
Rituxan | Rituximab | Monoclonal antibody | CD20 |
Raptiva | Efalizumab | Monoclonal antibody | CD11a |
Remicade | Infliximab | Monoclonal antibody | Tumor necrosis factor α |
CellCept | Mycophenolate mofetil | Small molecule prodrug | Inosine monophosphate dehydrogenase |